Clinical and histological characteristics of papillary thyroid microcarcinoma : Results of a retrospective study in 243 patientsROTI, Elio; ROSSI, Roberta; TRASFORINI, Giorgio et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 6, pp 2171-2178, issn 0021-972X, 8 p.Article

Fibroblast growth factor receptors as molecular targets in thyroid carcinomaBERNARD, Rosanne St; LEI ZHENG; WEI LIU et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 3, pp 1145-1153, issn 0013-7227, 9 p.Article

Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinomaBRAVO, Susana B; GARCIA-RENDUELES, Maria E. R; SEOANE, Rafael et al.Clinical cancer research. 2005, Vol 11, Num 21, pp 7664-7673, issn 1078-0432, 10 p.Article

Unusual uptake of radioiodine in the chest in a patient with thyroid carcinomaNAIR, N; BASU, S; PAKHALE, H et al.British journal of radiology. 2004, Vol 77, Num 913, pp 63-67, issn 0007-1285, 5 p.Article

Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell linesCERUTTI, J. M; EBINA, K. N; MATSUO, S. E et al.Journal of endocrinological investigation (Testo stampato). 2003, Vol 26, Num 6, pp 516-521, issn 0391-4097, 6 p.Article

Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinomaLIU, Ying Y; STOKKEL, Marcel P; PEREIRA, Alberto M et al.European journal of endocrinology. 2006, Vol 154, Num 4, pp 525-531, issn 0804-4643, 7 p.Article

Survival and death causes in differentiated thyroid carcinomaEUSTATIA-RUTTEN, Carmen F. A; CORSSMIT, Eleonora P. M; BIERMASZ, Nienke R et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 1, pp 313-319, issn 0021-972X, 7 p.Article

Clinical manifestations of familial medullary thyroid carcinomaKAMEYAMA, Kaori; OKINAGA, Hiroko; TAKAMI, Hiroshi et al.Biomedicine & pharmacotherapy. 2004, Vol 58, Num 6-7, pp 348-350, issn 0753-3322, 3 p.Article

S100A4 expression is an early event of papillary carcinoma of the thyroidITO, Yasuhiro; YOSHIDA, Hiroshi; TOMODA, Chisato et al.Oncology. 2004, Vol 67, Num 5-6, pp 397-402, issn 0030-2414, 6 p.Article

Medullary thyroid carcinoma: a rare presentation as a hypervascular tumourLI, W. Y; TOMLINSON, M. A; BRYSON, J. M et al.Journal of laryngology and otology. 2002, Vol 116, Num 8, pp 647-649, issn 0022-2151Article

Thyroid hormone receptor β mutations in the 'hot-spot region' are rare events in thyroid carcinomasROCHA, Ana Sofia; MARQUES, Ricardo; BENTO, Ines et al.Journal of endocrinology. 2007, Vol 192, Num 1, pp 83-86, issn 0022-0795, 4 p.Article

The multiplicity of thyroid nodules and carcinomasUTIGER, Robert D.The New England journal of medicine. 2005, Vol 352, Num 23, pp 2376-2378, issn 0028-4793, 3 p.Article

Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomasMCCARTHY, Ryan P; MINGSHENG WANG; JONES, Timothy D et al.Clinical cancer research. 2006, Vol 12, Num 8, pp 2414-2418, issn 1078-0432, 5 p.Article

Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogsTEUNISSEN, Jaap J. M; KWEKKEBOOM, Dik J; KRENNING, Eric P et al.Trends in endocrinology and metabolism. 2006, Vol 17, Num 1, pp 19-25, issn 1043-2760, 7 p.Article

Carcinome sarcomatoïde biphasique de la thyroïde : localisation exceptionnelle d'une tumeur rare = Biphasic sarcomatoid carcinoma of the thyroid : an exceptional localization of a rare tumorZNATI, K; TADLAOUI, N; BERNOUSSI, Z et al.Annales d'endocrinologie. 2006, Vol 67, Num 1, pp 64-68, issn 0003-4266, 5 p.Article

Expression of S100A2 and S100A6 in thyroid carcinomasITO, Y; YOSHIDA, H; TOMODA, C et al.Histopathology. 2005, Vol 46, Num 5, pp 569-575, issn 0309-0167, 7 p.Article

Management of the locally aggressive thyroid carcinomaWEIN, Richard O.American journal of otolaryngology. 2005, Vol 26, Num 3, pp 186-192, issn 0196-0709, 7 p.Article

A rare case of mucoepidermoid carcinoma of the thyroidBHANDARKAR, Naveen D; CHAN, James; STROME, Marshall et al.American journal of otolaryngology. 2005, Vol 26, Num 2, pp 138-141, issn 0196-0709, 4 p.Conference Paper

Prevention, evaluation, and management of complications following thyroidectomy for thyroid carcinomaZARNEGAR, Reza; BRUNAUD, Laurent; CLARK, Orlo H et al.Endocrinology and metabolism clinics of North America. 2003, Vol 32, Num 2, pp vii-viii, issn 0889-8529, 21 p.Article

Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomasLIN, Jen-Der; CHAO, Tzu-Chieh; HSUEL, Chuen et al.Clinical endocrinology (Oxford. Print). 2007, Vol 66, Num 2, pp 224-228, issn 0300-0664, 5 p.Article

TNM classification of thyroid carcinoma : Evidence-based endoctrine surgery: Thyroid cancerSHAHA, Ashok R.World journal of surgery. 2007, Vol 31, Num 5, pp 879-887, issn 0364-2313, 9 p.Article

Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelinesDELANEY, Geoff; JACOB, Susannah; BARTON, Michael et al.Cancer. 2006, Vol 106, Num 2, pp 453-465, issn 0008-543X, 13 p.Article

Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in Medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanismZATELLI, Maria Chiara; LUCHIN, Andrea; PICCIN, Daniela et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 10, pp 5754-5760, issn 0021-972X, 7 p.Article

Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomyGORGES, R; MANIECKI, M; JENTZEN, W et al.European journal of endocrinology. 2005, Vol 153, Num 1, pp 49-55, issn 0804-4643, 7 p.Article

Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARγ fusion oncogeneLUI, Weng-Onn; FOUKAKIS, Theodoros; LIDEN, Johan et al.Oncogene (Basingstoke). 2005, Vol 24, Num 8, pp 1467-1476, issn 0950-9232, 10 p.Article